A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS)
Clinical trial NCT05546905 · COMPLETED
Trial details
- NCT number
- NCT05546905
- Sponsor
- Pierre Fabre Medicament
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-23
- Primary completion
- 2025-01-07
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.